ViaCyte Alternatives & Competitors
12 companies similar to ViaCyte — Regenerating Health: Transforming the lives of patients with insulin-requiring d...
Companies similar to ViaCyte
Kadimastem Ltd.
A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for AL...
BlueRock Therapeutics
Striving to transform the treatment of disease by harnessing the power of cell therapy
Stemedica Cell Technologies, Inc
Developing Breakthrough Progenitor Cell and Protein Therapeutics
Blue Cell Therapeutics
We are dedicated to develop novel stem cell therapies to treat chronic diseases
Rival Readout
Competing with ViaCyte? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
PrimeCell Bioscience, a.s.
Měníme klasické paradigma léčby
TreeFrog Therapeutics
Cell Therapy for All
APstem Therapeutics
An unprecedented era of stem cell therapy has arrived!
Gallant
Restoring Health. Redefining Veterinary Care. Off-the-shelf stem cell therapies that targe...
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
Cellcolabs
Cellcolabs mission is to prevent and cure diseases by making high quality stem cells avail...
Fractyl Health
Dedicated to novel therapies that can sustain long term weight management.
About ViaCyte
ViaCyte is a biotechnology startup from the United States, focused on developing revolutionary cell replacement therapies for long-term diabetes treatment, aiming to achieve glucose control targets and reduce the risk of hypoglycemia and diabetes-related complications. ViaCyte's product candidates are rooted in the dir...
Regenerative Medicine, Cell Therapy, Diabetes Treatment, Stem Cell Therapy, Pancreatic Islet Progenitor Cells, Type 1 Diabetes, Insulin Replacement Therapy, Clinical Evaluation, Immuno-evasive Therapy, Collaborative Partnerships, CRISPR Therapeutics, W.L. Gore & Associates, Chronic Disease Management, Medical Device Innovation, Cell Differentiation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ViaCyte: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ViaCyte on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.